Asset Details
Do you wish to reserve the book?
Proteomic Insights into the Retinal Response to PRGF in a Mouse Model of Age-Related Macular Degeneration
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Proteomic Insights into the Retinal Response to PRGF in a Mouse Model of Age-Related Macular Degeneration
Do you wish to request the book?
Proteomic Insights into the Retinal Response to PRGF in a Mouse Model of Age-Related Macular Degeneration
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Proteomic Insights into the Retinal Response to PRGF in a Mouse Model of Age-Related Macular Degeneration
2025
Overview
Background and Objectives: The aim of this study is to employ quantitative proteomics to elucidate the molecular mechanism and signaling pathways modulated by plasma rich in growth factors (PRGF) in a murine model of geographic atrophy (GA)-like retinal degeneration. Materials and Methods: C57BL/6J mice were used as a model GA-like retinal degeneration by a single systemic NaIO3 administration. Animals were divided into three groups: Control (PBS), Disease (NaIO3 + PBS), and PRGF-treated (NaIO3 + PRGF). After 7 days, retinas and retinal pigment epithelium were collected for proteomic analysis. Proteins were extracted, digested using the FASP method, and analyzed by Data-Independent Acquisition (DIA-PASEF) mass spectrometry; data were processed with DIA-NN and statistically analyzed with Perseus. Functional pathway analysis was performed using Ingenuity Pathway Analysis. Results: A total of 6511 proteins were identified. The Disease model showed the expected deregulation of pathways related to oxidative stress, inflammation, and fibrosis. Comparison between the PRGF and Control groups showed that PRGF significantly reduced oxidative and cellular stress proteins/pathways. In the same way, when PRGF and Disease groups were compared, PRGF treatment showed a significant reduction in pathways associated with inflammation, oxidative stress, and cellular stress. PRGF also activated several homeostatic pathways not only related to neuroprotective pathways but also with the lipid deposition (drusen) reduction. All these results suggest that PRGF treatment exerts a protective effect against NaIO3-induced retinal damage. Conclusions: These findings suggest that PRGF effectively mitigates the degenerative effects of NaIO3 by activating specific protective and compensatory signaling pathways in the retina. PRGF is indicated as a promising new therapeutic option for ameliorating age-related macular degeneration progression.
Publisher
MDPI AG,Multidisciplinary Digital Publishing Institute (MDPI)
Subject
age-related macular degeneration (AMD)
/ Analysis
/ Animals
/ Atrophy
/ Ethylenediaminetetraacetic acid
/ Intercellular Signaling Peptides and Proteins - pharmacology
/ Intercellular Signaling Peptides and Proteins - therapeutic use
/ Iodates
/ Macular Degeneration - drug therapy
/ Macular Degeneration - physiopathology
/ Mice
/ Oxidative Stress - drug effects
/ Peptides
/ Plasma
/ plasma rich in growth factors (PRGF)
/ Proteins
/ Retina
/ retinal pigment epithelial cell
/ Signal Transduction - drug effects
/ Sodium
